Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic Triad  by Chen, Ping et al.
Cell, Vol. 86, 835–843, September 6, 1996, Copyright 1996 by Cell Press
Structure of the Human Cytomegalovirus
Protease Catalytic Domain Reveals
a Novel Serine Protease Fold and Catalytic Triad
Ping Chen, Hideaki Tsuge,* Robert J. Almassy, C-terminal maturation (M-) site. Additionally, HCMV pro-
tease–catalyzed autoproteolysis occurs between Ala-Cindy L. Gribskov, Susumu Katoh,*
Darin L. Vanderpool, Stephen A. Margosiak, 256 and Ser-257 at the release (R-) site. The released
28 kDa catalytic domain comprises amino acid residuesChristopher Pinko, David A. Matthews,
and Chen-Chen Kan 1–256 and retains full protease activity. Only b herpesvi-
ruses have additional autoproteolytic cleavage sitesAgouron Pharmaceuticals
3565 General Atomics Court within the protease catalytic domain. For HCMV prote-
ase, these internal cleavage (I-) sites are between, inSan Diego, California 92121
the first instance, Ala-143 and Ala-144; and in thesecond
instance, Ala-209 and Ser-210 (Jones et al., 1994). In
transfections (Welch et al., 1993) and in viral infectionsSummary
(Jones et al., 1994), proteolytic cleavage of UL80 occurs
at the M-site first, followed in order by the R-site andProteolytic processing of capsid assembly protein
then the I-sites. Mutant HSV-1 viruses that fail to cleaveprecursors by herpesvirus proteases is essential for
the protease at the R-site or the assembly protein pre-virion maturation. A 2.5 A˚ crystal structure of the hu-
cursor at the M-site do not produce infectious virusman cytomegalovirus protease catalytic domain has
(Matusick-Kumar et al., 1995).been determined by X-ray diffraction. The structure
Herpesvirus proteases share considerable amino aciddefines a new class of serine protease with respect
sequence homology. There are five cysteine residues into global-fold topology and has a catalytic triad con-
the HCMV protease catalytic domain, none of whichsisting of Ser-132, His-63, and His-157 in contrast with
form disulfide bonds. Only one cysteine, Cys-161 inthe Ser-His-Asp triads found in other serine proteases.
HCMV protease, is conserved among all herpesvirusHowever, catalytic machinery for activating the serine
proteases. It has been reported that the enzyme losesnucleophile and stabilizing a tetrahedral transition
catalytic activity if Cys-161 is oxidizedto form a disulfidestate is oriented similarly to that for members of the
bond with Cys-138 (Baum et al., 1996) or modified bytrypsin-like and subtilisin-like serine protease families.
alkylating agents (Burck et al., 1994). However, basedFormation of the active dimer is mediated primarily by
on modification of reactive serine residues by di-isopro-burying a helix of one protomer into a deep cleft in
pylfluorophosphate (DiIanni et al., 1994), herpesvirusthe protein surface of the other.
proteases have been proposed to be serine proteases,
although they have no amino acid sequence homologyIntroduction
with any other known serine proteases. Mutagenesis
results for HCMV protease (Cox et al., 1995) suggestHuman cytomegalovirus (HCMV) is a b herpesvirus be-
that His-63, Glu-122, and Ser-132 may form a catalyticlonging to the Herpesviridae family, which includes her-
triad required for proteolytic activity. Recently, we andpes simplex virus -1 and -2 (HSV-1, HSV-2) and Epstein
others have independently demonstrated that the activeBarr virus (EBV) from the a and g herpes subgroups,
HCMV protease catalytic domain forms an obligate di-respectively. Viral infection by HCMV is common, with
mer with a Kd of 5 mM (Margosiak et al., 1996; Darke et40%–80% of the human population infected prior to
al., 1996).adulthood (Gold and Nankervis, 1982). For immunocom-
We are interested in HCMV protease as an antiviralpromised individuals, HCMV is a serious pathogen that
drug target and a member of an apparently novel classcan cause fatal organ damage.
of serine protease. Using a recombinant enzyme purifiedAll herpesviruses encode a protease that cleaves a
from Escherichia coli as described previously (Pinko etmajor component of the intermediate capsid, theassem-
al., 1995), we have determined the three-dimensionalbly protein precursor, during capsid maturation. This
structure of HCMV protease catalytic domain.proteolytic processing is essential for virion maturation
(Preston et al., 1983; Liu and Roizman, 1991). Herpesvi-
rus proteases are, therefore, considered to be attractive Results and Discussion
molecular targets for antiviral drug development. HCMV
protease is a 708 amino acid protein encoded by the Overall Structure and Novel Catalytic Triad
UL80 open reading frame. The gene for the assembly The catalytic domain of HCMV protease is an a/b protein
protein precursor, although nested inside of and 39-co- consisting of a central core comprising two orthogonal
terminal with the UL80 open reading frame (Welch et four-stranded b sheets surrounded by eight a-helices
al., 1991), is transcribed separately. Thus, the full-length (Figure 1). A sequence alignment for representative
HCMV protease(UL80) and theassembly protein precur- members of the herpesvirus protease family, along with
sor share an identical sequence of 373 amino acids. secondary structure assignments based on the three-
HCMV protease cleaves the assembly protein precur- dimensional structure of HCMV protease, are given in
sor and itself between Ala-643 and Ser-644 at the Figure 2. Twisting of the two central b sheets brings
them close together at one corner, where b3 in the top
sheet bends approximately 908 at conserved Gly-70 and*Permanent address: Japan Tobacco Inc., Central Pharmaceutical
Research Institute, 1-1, Murasaki-cho Takatsuki, Osaka 569, Japan. passes directlyacross into the other sheet, forming what
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Figure 1. View of the HCMV Protease Catalytic Domain Oriented to
Highlight the Core b Sheets
Strands are shown in yellow, a-helices in blue, and connecting loops
in purple.
has been termed a right-handed triple-stranded corner
(Efimov, 1992). Individual b strands in the lower sheet
are longer and extend out from underneath those in the
upper sheet, where they are covered at one end by helix
a1 and the extended loop connecting b1 to a1 and at
the other end by helices a2 and a4. A pair of other
helices (a5 and a6) shield the back side of the large
lower b sheet. The remaining helices (a3, a7, and a8)
along with portions of a2 and a4, are positioned near
one edge of the b sandwich where the two sheets splay
apart, creating a pronounced depression in the protein
surface. Dimerization of HCMV protease is mediated by
burying four turns of helix a7 from one protomer into
this complementary cleft on the other (Figure 3).
His-63 and Ser-132 are located on the solvent-
exposed surface of the upper b sheet. The imidazole Figure 2. Secondary Structure Assignments for the HCMV Protease
side chain of His-63 is positioned above the sheet and Catalytic Domain and Sequence Alignments for Catalytic Domains
within hydrogen-bonding distance of the Ser-132 hy- of Representative Herpesvirus Proteases
droxyl. Both residues are conserved among all known a-helices and b strands are marked as a1–a8 and b1–b8, respec-
tively. HSV-1, herpes simplex-1; HCMV, human cytomegalovirusamino acid sequences of herpesvirus proteases. On the
strain AD169; MCMV, mouse CMV; ColCMV, simian CMV strain Col-basis of amino acid sequence alignments and mutagen-
burn; EBV, Epstein Barr virus.esis experiments, it has been proposed that His-63, Ser-
132, and Glu-122 form a catalytic triad inHCMV protease
Residues 1–7, 46–55, 139–154, and 200–211 are not(Cox et al., 1995) similar to the well-studied Ser-His-Asp
modeled in the current structure because electron den-catalytic triads in trypsin-like and subtilisin-like serine
sity for these residues is weak and poorly defined. Se-proteases. Crystallographic evidence supports the iden-
quence alignments (see Figure 2) indicate that the un-tification of His-63 and Ser-132 as the essential catalytic
modeled amino acids have little homology with residuescouple. Glu-122 on a4, however, is more than 20 A˚ from
in corresponding connecting loops of other herpesvirusHis-63 in both protomers and therefore cannot contrib-
proteases. A pair of the loops span known autoproteo-ute directly to substrate binding or catalysis. In fact,
lytic cleavage sites at residues 143 and 209 (Jones etthere are no acidic residues in the vicinity of His-63 that
al., 1994) and are likely to be flexible and loosely struc-could participate in forming a classical catalytic triad.
tured in solution.A second conserved histidine (His-157) hydrogen bonds
to the imidazole of the His-63 in each of the four crys-
Transition-State Stabilizationtallographically independent HCMV protease polypep-
Substrate hydrolysis by serine proteases occurstide chains, suggesting that a previously unrecognized
through a covalent tetrahedral intermediate resultingvariation of the classical Ser-His-Asp catalytic triad ex-
from attack of the active-site nucleophile on the car-ists in HCMV protease comprising Ser-132, His-63, and
His-157. bonyl carbon of the scissile bond. In all known serine
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of conserved Leu-32 and Leu-133 for Arg-166. The crys-
tallographic evidence suggests that these conserved
arginine residues provide a cationic environment for sta-
bilization of the oxyanion in the transition state. It is
possible that substrate binding could induce conforma-
tional changes that would allow either or both arginine
side chains to hydrogen-bond directly with the oxya-
nion. But this would involve disrupting preexisting pro-
tein hydrogen bonds and would therefore provide less
transition-state stabilization than equivalent preformed
scaffolding.
Comparison with Other Serine Proteases
The HCMV protease structure defines a new class of
serine protease with an overall polypeptide fold distinct
from that of other hydrolytic enzymes. However, the
active site is remarkably similar in certain respects to
those for proteins in the trypsin-like and subtilisin-like
families of serine proteases. Geometrical similarities forFigure 3. HCMV Protease Catalytic Domain Dimer, Viewed Down
representative members of these families can be seenthe 2-Fold Axis
in Figure 5, where functionally equivalent atoms inHCMVa-helices are shown in blue, and the two central b sheets are shown
in yellow. protease, trypsin (Protein Data Base entry 1smf), and
subtilisin (PDB entry 2sec) are superposed. A structural
template for HCMV protease consisting of the His-63proteases, esterases, and lipases and in papain-like cys-
imidazole, Ser-132 Og, His-157 Ne2, and the backboneteine proteases as well, distortion of the carbonyl of
amide of Arg-165 aligns geometrically to correspondingthe substrate is stabilized by strong hydrogen bonds
templates in trypsin and subtilisin with root-mean-between the developing oxyanion and the amide groups
square differences of 0.38 A˚ and 0.76 A˚, respectively.of the enzyme. If the hydrolytic mechanism of HCMV
These results indicate that, while the backbone foldsprotease proceeded through a tetrahedral intermediate,
are quite different, the catalytic machinery for activatingwe would expect to find protein architecture for oxy-
the serine nucleophile, stabilizing the tetrahedral transi-anion recognition in the vicinity of Ser-132. Among all
tion state, and protonating the leaving group nitrogen ofenzymes cited above, oxyanion stabilization involves
the substrate is similarly disposed in all three enzymes.either two or three hydrogen bond donors, one of which
An obvious difference between HCMV protease andinvariably is the backbone amide of the serine (or cyste-
the trypsin-like and subtilisin-like proteases is the sub-ine) nucleophile itself or the amino acid immediately
stitution of histidine for aspartic acid as the third mem-following it. In HCMV protease, the backbone amide
ber of the catalytic triad. A negatively charged asparticgroup of Ser-132 and those of adjacent residues in b6
acid is thought to be important for stabilizing a chargedare involved in antiparallel hydrogen bonding to main-
imidazole in the transition state. Replacement of thischain carbonyl groupsof residues in b7 (Figure 4). There-
aspartate with neutral amino acids in trypsin and subti-fore, none of these backbone amides is available for
lisin reduces kcat by around 103–104-fold for both en-hydrogen bonding to the developing oxyanion. A rigid
zymes (Corey and Craik, 1992; Carter and Wells, 1988).loop in HCMV protease, consisting of seven residues
His-157 mutants of herpesvirus proteases have not been(163–169) connecting b7 to b8, is positioned above Ser-
characterized kinetically, but in some cases the mutated132 and forms the molecular scaffolding for oxyanion
enzymes retain activity in transfection assays with as-stabilization. The signature sequence in this loop of G-R-
sembly protein precursor (Cox et al., 1995). This sug-R-X-G-T is absolutely conserved in all 14 known amino
gests that the role of His-157 may be more to positionacid sequences of herpesvirus proteases (Gibson,
His-63 for protonextraction from Ser-132 Og and subse-1994). The backbone NH of Arg-165 points directly into
quent delivery to the leaving group nitrogen of the sub-a small pocket just above Ser-132 Og, which is occupied
strate, rather than for electronic stabilization of the tran-by an ordered water molecule in each of the four crystal-
sition state. The kcat for D102N mutant trypsin is 3.0/lographically independent polypeptide chains. This wa-
min, which is close to that for HCMV protease (18/min;ter hydrogen bonds to both the Arg-165 backbone am-
Pinko et al., 1995). A potentially interesting mutation ofide and to Ser-132 Og. Its position probably indicates the
HCMV protease would be to change His-157 to glutamicapproximate location of the oxyanion of the tetrahedral
acid (an aspartic acid side chain would be too shortintermediate during catalysis. The guanidinium side
for hydrogen bonding with Nd1 of His-63) to test thechains of Arg-165 and Arg-166 extend outward approxi-
hypothesis that an acidic amino acid at this position ofmately parallel to one another across the top of the
the catalytic triad could elevate kcat.oxyanion binding site. Their geometry relative to the
“oxyanion hole” and to each other is maintained by
charge-mediated hydrogen bonds to acidic residues in The HCMV Protease Dimer and Enzyme Activity
The catalytic domain dimer of HCMV protease has athe loop connecting b1 to a1 for Arg-165 and by hydro-
gen bonding to the backbone carbonyl oxygen atoms dissociation constant of 5–8 mM (Darke et al., 1996;
Cell
838
Figure 4. Stereo View of the HCMV Protease Active Site and Surrounding Residues
The catalytic triad, Arg-165, and Arg-166 are represented with thick bonds. Drawn as spheres with stick bonds is a model peptide showing
how the P2 to P1’ (Asn-Ala-Ser) portion of a substrate could be positioned within the active-site cleft. A larger sphere marks the iodine position
in an iodotyrosine-containing tetrapeptide aldehyde inhibitor bound to the HCMV protease (see text).
Margosiak et al., 1996). The dimer has two well-sepa- pronounced groove in the surface of the other subunit
(Figure 6). Amino acids immediately N-terminal to a7rated active sites (35 A˚ between the side-chain hy-
droxyls of Ser-132 in each protomer) that may function plus residues along one face of this helix directly interact
with the loop that orients catalytically important His-63.independently. For small synthetic peptides, binding de-
terminants probably reside within a single subunit, since Any repositioning of the “dimerization helix” a7 and its
connecting loop upon dissociation into monomers couldthe distal protomer approaches no closer than 12 A˚ to
the scissile peptide bond of a substrate modeled into affect the placement of His-63 and inactivate the en-
zyme. The side-chain carboxylate of Glu-122 hydrogen-the other active site. Dimer formation is mediated by
symmetrical docking of helix a7 of one subunit into a bonds to protein segments involved in dimer formation.
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six water-filled cavities at the dimer interface and by
low sequence homology for amino acids in a7 among
all 14 known herpesvirus proteases. This could explain
the weak association of the protease dimer, which may
have a functional role in the viral life cycle. Proteolysis of
the assembly protein precursor leading to its structural
dissolution and entry of the viral genome occurs in the
nucleus (Gibson et al., 1990) under conditions in which
the local concentration of the viral protease must be
considerably higher than in cytoplasm.Since HCMVpro-
tease and, most probably, other herpesvirus proteases
are inactive as monomers, a weak association may keep
the protease primarily monomeric in the cytoplasm, thus
assuring that assembly protein precursors are not pre-
maturely processed before being transported to the nu-
cleus for construction of the viral capsid scaffold.
Substrate Binding
The substrate binding site of HCMV protease (see Figure
4) is an elongated shallow cleft in the surface of the
protein extending in opposite directions from Ser-132,
suggesting that the enzyme has recognition elements
for amino acids on both sides of the scissile peptide
bond of the substrate. This is consistent with results
from studies of substrate specificity showing that effi-
cient cleavage minimally requires amino acid residues
spanning the P4 to P4’ positions (Vinoid et al., 1994).
Herpesvirus proteases cleave at several different but
Figure 5. View of Superposed Catalytic Triads and Oxyanion Bind- related sites (e.g., the M-, R-, and I-sites) having the
ing Sites for HCMV Protease (Yellow), Trypsin (Green), and Subtilisin general consensus sequence (V/I/L)XA↓(A/S) where P3
(Pink)
is usually valine, P1’ is usually serine, and X at P2 can be
asparagine, aspartate, glutamine, glutamate, or lysine
(Gibson et al., 1994).Mutations of Glu-122 that result in loss of HCMV prote-
ase activity may produce structural changes at thedimer In attempting to model how peptide substrates bind,
we were guided by the similar arrangement of catalyticinterface leading to the accumulation of inactive mo-
nomers. residues in trypsin and HCMV protease and by theexten-
sive database of X-ray structures that exist for trypsin-Temporal and spatial regulation of herpesvirus prote-
ase activity in an infected cell could be regulated by like serine proteases complexed with peptide inhibitors.
Since the relative dispositions of the catalytic histidinedimerization. Nonoptimal matching of the HCMV prote-
ase oligomer interface is suggested by the presence of imidazole, the nucleophilic serine, and the oxyanion hole
Figure 6. View of the HCMV Protease Dimer
Interface Showing Helix a7 from One Pro-
tomer and the Molecular Surface of the Other
Protomer
Helix a7 sits in a groove formed by five helices
from the second subunit, one of which is a79
(primed secondary structure elements refer
to those in the second subunit). The surface
of a79 is directly to the left of a7.
Cell
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Table 1. Statistics for the Crystallographic Analysis
Crystal NativeI1 NativeII2 HgI1 HgII2
Soak concentration3 — — 1/10K 1/1K
Soak time (hr) — — 90 74
Internal merging and scaling
Resolution (A˚) 3.5 2.5 3.5 2.9
Reflections measured 52932 117752 52551 115741
Unique reflection 12384 32525 12578 23431
Completeness (%) 86 91 91 98
Average I/s 17.3 21.0 14.0 27.4
Rsym4 6.7 3.5 7.7 5.4
SIRSAS analysis
Resolution (A˚) 1523.5
Rcullis5 0.54
Phasing power6 (SIR/SAS) 3.1/1.94
Figure of merit 0.676
SAS analysis
Resolution (A˚) 1523.5
Phasing power 1.90
Figure of merit 0.388
1 Data collected on dual Xuong-Hamlin multiwire area detectors at 48C.
2 Data collected on MAR imaging plate at 21708C.
3 Hygroscopic crystalline salt of Na2Hg(SCN)4 had absorbed an indeterminate amount of water. For heavy atom soaking, 1 ml of the dissolved
mercury containing salt (unknown concentration) was added to 10 ml (HgI) or 1 ml (HgII) of the protein mother liquor.
N — N
4 Rsym 5 SS | I (h)2I(h)i|/ SS I(h)i*100
h h i51i51
where I(h)i is the ith measurement of reflection h and I(h) is the mean value of the N equivalent reflections.
5 Rcullis 5 S||FPH 1/2 FP|2FH(calc)|/S|FPH 1/2 FP| for all centric reflections.
6 Phasing power 5 root-mean-square (|FH|/E), where |FH| is the heavy-atom structure factor amplitude and E is the residual lack of closure.
are the same in HCMV protease and trypsin, the handed- to that for substrate binding to trypsin-like serine prote-
ases, where a similarly exposed b strand makes antipar-ness of the tetrahedral intermediates (Garavito et al.,
1977) in the two cases must also be the same. This allel b sheet–type hydrogen bonds with substrate in an
extended conformation. For herpesvirus proteases, therequires that peptide substrate residues on the N-termi-
nal side of the scissile bond be bound in the upper P2 residue is variable, which is consistent with our posi-
tioning of the P2 side chain adjacent to His-63 but point-portion of the active-site cleft, as viewed in Figure 4.
We have recently determined a low resolution structure ing into bulk solvent. The backbone carbonyl oxygen at
P2 is positioned to hydrogen-bond to the guanidiniumfor HCMV protease in a second crystal form both as
the apoenzyme and as a complex with the iodinated side chain of Arg-165. Beyond this point, the modeling
becomes more problematic because without some ad-tetrapeptide aldehydeinhibitor (iodo-Y-V-N-A-aldehyde,
Ki 5 3 mM). Difference maps show a large peak at ap- justment of the protein, particularly in the loop connect-
ing b1 to a1, which forms one edge of the binding cleft,proximately the position expected for an iodine-con-
taining tetrapeptide bound to the protease in an ex- it is difficult to satisfy all the substrate main-chain hydro-
gen bonding requirements. A detailed description oftended conformation.
In order to study possible substrate binding modes peptide binding to HCMV protease must await a high
resolution cocrystal structure determination.in more detail, we applied the same transformation that
maps thecatalytic template of trypsin onto that of HCMV
protease to a modified version of the trypsin/Bowman Implications
An X-ray structure of the HCMV protease catalytic do-Birk inhibitor complex X-ray structure (PDB entry 1smf),
in which inhibitor side chains were changed to match a main reveals the protein to be a member of a new class
of serine protease with respect to global fold, topology,consensus sequence for the HCMV protease cleavage
site. This comparison suggests that the P1 alanine of and quaternary structure. The structure confirms that
His-63 and Ser-132 are essential residues that togetherthe substrate fits into a shallow buried pocket formed
by conserved Leu-32 and aliphatic portions of the Arg- with a third amino acid, His-157, form a catalytic triad
with similarities to the Ser-His-Asp triads in trypsin-like166 guanidinium side chain. On the leaving group side
of the scissile bond, the P1’ residue must be oriented and subtilisin-like serine proteases. Recognition ele-
ments for oxyanion transition-state stabilization residewith its side chain in a small pocket formed by Asn-62
and His-63. A large amino acid side chain can not be in a short highly conserved hexapeptide loop that pro-
vides both hydrogen bonding and charge-neutralizationaccommodated here, while a possible hydrogen bond
between Ser at P1’ and the side chain of Asn-62 is in functionality. Although HCMV protease, trypsin, and
subtilisin have unrelated amino acid sequences andagreement with the observed preference at P1’ of Ser>
Ala>Gly>>Thr (Vinoid et al., 1994). Residues N-terminal structural scaffolds, geometrical arrangement of their
catalytic triads and architecture for stabilizing the oxya-to the P1 alanine must align themselves along the ex-
tended strand b7 that forms the bottom of the active- nion transition state for peptide cleavage is nearly identi-
cal in the three enzymes, providing one of the few clear-site groove. In certain respects, this geometry is similar
Structure of Human Cytomegalovirus Protease
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Figure 7. A Portion of the Averaged Solvent-
Flattened ISAS Electron Density Map Calcu-
lated at 2.9 A˚ Resolution and Contoured at
2.5 s
Superposed on the density is the final refined
model.
HCMV protease studied here for the purpose of optimizing crystalli-cut examples of convergent evolution at the level of
zation properties. All five mutated residues are on the surface loops.enzyme catalysis. An intriguing aspect of the structure
Compared to A143Q mutant HCMV protease, the five-site mutantis a four-turn a-helix that docks into a crevice from
protease possesses 30% higher proteolytic activity.
a second subunit to form active homodimeric HCMV
protease.
Protein Crystallization and Data Collection
The importance of HCMV protease for viral replication Crystals were grown at 138C using a hanging drop vapor diffusion
in infected cells is well documented, thus establishing method. Aliquots (5 ml) of protein solution at a concentration of 10
the protein as a validated target for antiviral drug design. mg/ml were mixed with equal volumes of a reservoir solution and
sealed over individual wells filled with 1 ml of 0.2M MES (pH 6.0),Our structure suggests several possible ways in which
400 mM NaCl, 12% PEG 3.4K, 5 mM EDTA, and 20% DMSO. Thethis goal could beaccomplished. Because of theshallow
crystals were shown to belong to space group C2221, with cellspecificity pockets atS1 and S1’, it is likely that inhibitors
parameters a 5 105.74 A˚, b 5 113.38 A˚, and c 5 185.26 A˚. Cell
will require covalent association with the catalytic nu- parameters for crystals frozen at 21708C were a 5 104.48 A˚, b 5
cleophile Ser-132 or nearby conserved Cys-161 (Figure 111.89 A˚, and c 5 181.23 A˚. There are four monomers in the asym-
4). Others have shown that alkylation of Cys-161 ordisul- metric unit corresponding to a solvent content of 48%. Crystals
diffracted well to 2.3 A˚ resolution. X-ray diffraction data were col-fide bond formation between Cys-161 and Cys-138 inac-
lected either at 48C, using dual Xuong-Hamlin multiwire area detec-tivates HCMV protease (Burck et al., 1994; Baum et al.,
tors, or at 21708C, using a MAR imaging plate and processed by1996). The structure suggests that this is accomplished
DENZO (Otwinowski, 1993). Data collection with the Xuong-Hamlin
by blockingsubstrate access to the activesite. Inhibitors detectors was limited to 3.5 A˚ resolution because of the long c axis.
with specificity for HCMV protease might take advan-
tage of binding determinants in a pronounced pocket
Heavy Atom Phasing
beyond S1’ on the leaving group side of the active site. Initial heavy atom screening was carried out at 3.5 A˚ resolution
Alternatively, small molecules that interact with the a7 using crystals cooled to 48C. Diffraction data for a crystal soaked
in Na2Hg(SCN)4 were used to calculate isomorphous and anomalousbinding crevice could inhibit HCMV protease by shifting
difference Patterson maps from which three consistent sites ofthe equilibrium to favor inactive monomers. A strategy
heavy atom substitution were derived. Difference Fourier methodsfor disrupting dimer formation is attractive in this case
were used to locate five additional heavy atom sites. The positionalbecause the oligomer interface is characterized by a
and thermal parameters and relative occupancies for the eight heavy
deep helix binding pocket, but subunit association, at atom sites were refined using programs PHASES (Furey and Swa-
least for the catalyticdomain of HCMV protease, is weak. minathan, 1990) and HEAVY (Terwilliger and Eisenberg, 1983) at
3.5 A˚. The handedness of the Hg positions was determined using
the approach of Wang (1985). SIR and anomalous data at 3.5 A˚ wereExperimental Procedures
combined. Cycles (4) of solvent flattening were then carried out
using phases calculated from the set of eight heavy atom positionsProtein Expression and Purification
The catalytic domain of the HCMV protease was expressed in E. in both the original and inverted configurations. The inverted Hg
positions gave the correct hand and were used in the subsequentcoli. Recombinant HCMV proteases were purified and proteolytic
activity was determined as described previously (Pinko et al., 1995). refinement. ISIRSAS maps revealed electron density for four mono-
mers in the asymmetric unit. Helices (5) in each monomer wereMutation of the A143Q eliminated autoproteolysis, allowing stable
28 kDa protease to be overproduced. A set of four additional muta- identified and modeled into ISIRSAS maps. Initial noncrystallo-
graphic (NC) symmetry operators relating the four molecules intions (C138L, D139G, R196S, and C202A) were introduced into the
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asymmetric unit were derived using the five helices ineach molecule. Burck, P.J., Berg, D.H., Luk, T.P., Sassmannshausen, L.M., Wakul-
chik, M., Smith, D.P., Hsiung, H.M., Becker, G.W., Gibson, W., andNC symmetry operators were then refined by least squares using
ISIRSAS maps at 3.5 A˚. An iterative process of solvent-flattening, Villarreal, E.C. (1994). Human cytomegalovirus maturational protein-
ase: expression in Escherichia coli, purification, and enzymatic char-symmetry averaging, back-transformation, and phase combination
was carried out. The resultant electron density maps were improved acterization by using peptide substrate mimics of natural cleavage
sites. J. Virol. 68, 2937–2946.greatly, and an initial backbone model was built. However, attempts
to fit individual amino acid side chains into these maps were unsuc- Carter, P., and Wells, J.A. (1988). Dissecting the catalytic triad of a
cessful. But this initial model was placed into a map generated from serine protease. Nature 332, 564–568.
21708C data, as described below.
Corey, D.R., and Craik, C.S. (1992). An investigation into the mini-Anomalous Patterson maps calculated using data from a
mum requirements for peptide hydrolysis by mutation of the cata-Na2Hg(SCN)4-soaked crystal at 21708 C showed good peaks; how- lytic triad of trypsin. J. Am. Chem. Soc. 114, 1784–1790.ever, the corresponding isomorphous Patterson maps were of much
Cox, G.A., Wakulchik, M., Sassmannshausen, L.M., Gibson, W., andpoorer quality, perhaps because of nonisomorphism caused by
Villarreal, E.C. (1995). Human cytomegalovirus proteinase: candi-freezing. Hg positions (8) were refined using only single anomalous
date glutamic acid identified as third member of putative active-sitescattering data at 4 A˚. Several cycles of solvent flattening were
triad. J. Virol. 69, 4524–4528.carried out, and the phases were extended for the measured diffrac-
tion data from 4.0 A˚ to 3.5 A˚. ISAS phases were then used to refine Darke, P.L., Cole, J.L., Waxman, L., Hall, D.L., Sardana, M.K., and
the Hg positions against 3.5 A˚ single anomalous scattering data. Kuo, L.C. (1996). Active human cytomegalovirus protease is a dimer.
The partial model generated from 48C data was then placed into J. Biol. Chem. 271, 7445–7449.
the 3.5 A˚ ISAS map. NC operators as well as masks for each of DiIanni, C.L., Stevens, J.T., Bolgar, M., O’Boyle, D.R., II, Weinheimer,
the four monomers were generated from these partial models. NC S.P., and Colonno, R.J. (1994). Identification of the serine residue
symmetry operators were refined by least squares using ISAS maps at the active site of the herpes simplex virus type-1 protease. J.
at 4.0 A˚. Again, an iterative process of solvent-flattening, symmetry Biol. Chem. 269, 12672–12676.
averaging, back-transformation, and phase combination was car-
Efimov, A.V. (1992). A novel super-secondary structure of b proteins:ried out. Phases were extended for the measured diffraction data
a triple-strand corner. FEBS Lett. 298, 261–265.from 3.5 A˚ to 2.9 A˚. Except for several loop regions, the resultant
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